ADIPOQ and non-small cell lung carcinoma: This effect further highlights the anti-tumoral potential of adiponectin as high levels of CREB have been identified in prostate cancer, breast cancer, non-small-cell lung cancer (NSCLC), and leukemia and correlates with cancer cells differentiation and poor prognosis [39].